This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

A Systematic, Patient-Centered Approach to Managing Metastatic Gastric or GEJ Adenocarcinoma

A Systematic, Patient-Centered Approach to Managing Metastatic Gastric or GEJ Adenocarcinoma

Format

Slide Lecture Series

Time to Complete

1 hour

Released

December 21, 2017

Expires

December 21, 2018
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CNE Contact Hour

Accredited Provider

Jointly provided by AKH Inc., Advancing Knowledge in Healthcare and RMEI Medical Education, LLC.

Commercial Supporter

This activity is supported by an educational grant from Lilly.

Program Description

Gastric cancer is among the leading causes of cancer-related deaths globally. The need for early detection and timely management is crucial because early stages of the disease are asymptomatic and initial diagnosis is often delayed. In most cases, gastric cancer is diagnosed at advanced stages with either metastatic or extensive locoregional disease. The best of a series of 5 live Grand Rounds discussing the most current challenges in managing gastric cancer is now available in an interactive, online, on-demand educational format featuring expert insight, patient case vignettes, polling questions, and peer benchmarking. This educational activity will explore the pathogenic and molecular development of gastric cancer, effective use of current and emerging treatment options, and strategies for implementing shared decision making (SDM) when treating patients with gastric cancer.

Intended Audience

This activity has been designed for oncology clinicians including physicians, nurses, and PAs.

Educational Objectives

After completing this activity, the participant will demonstrate the ability to:

  • Summarize the pathogenesis and molecular pathways involved in the development and progression of gastric cancer
  • Evaluate the safety, efficacy, and quality of data for available and emerging targeted therapies for locally advanced or metastatic gastric and gastroesophageal junction (GEJ) adenocarcinoma
  • Individualize and optimize treatment with sequencing and management of treatment-related adverse events for locally advanced or metastatic gastric and GEJ adenocarcinoma
  • Engage patients with locally advanced or metastatic gastric and GEJ adenocarcinoma in their care by implementing effective SDM strategies

Conflict Of Interest Disclosure Policy

It is the policy of RMEI Medical Education, LLC and AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by RMEI and AKH Inc. prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review. AKH Inc. planners and reviewers have no relevant financial relationships to disclose.

The faculty reported financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity under the Faculty heading below.

Faculty

Jaffer A. Ajani, MD
Professor of Medicine, Department of Gastrointestinal Medical Oncology
University of Texas MD Anderson Cancer Center
Houston, TX

Jaffer A. Ajani, MD, has affiliations with Bristol-Myers Squibb, Celgene, Genentech, Insys, Lilly, and Medscape (Consulting Fees), and Bristol-Myers Squibb and Delta-Fly (Contracted Research).

Accredited Provider Disclosure

AKH Inc. Staff and Planners
Dorothy Caputo, MA, BSN, RN
, Director of Accreditation, Planner, has no affiliations with commercial interests to disclose.
Patricia Brignoni, Sr. Project Manager, has no affiliations with commercial interests to disclose.

Publishing Staff Disclosures

RMEI Medical Education, LLC
Tania Dickson, MD
, has no affiliations with commercial interests to disclose.
Mindy Tanzola, PhD, has no affiliations with commercial interests to disclose.
Jacqui Brooks, MBBCh, MRCPsych, has no affiliations with commercial interests to disclose.
Jessica Hatch has no affiliations with commercial interests to disclose.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and RMEI Medical Education, LLC. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
The National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 Credit(s)TM  from organizations accredited by ACCME.

Credit

1.00

Type

CNE Contact Hour(s)

Accreditation Statement

AKH Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Jointly provided by RMEI Medical Education, LLC and AKH Inc., Advancing Knowledge in Healthcare.

Designation Statement

This activity is awarded 1.0 Contact Hour.

Disclosure of Unlabeled Use

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. and RMEI specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through the participant's misunderstanding of the content.

Instructions

By reviewing the course content and successfully completing the post-test and evaluation, physicians and PAs are entitled to receive up to 1.00 AMA PRA Category 1 Credit(s)TM  and nurses are entitled to receive up to 1.00 contact hour. A statement of credit will be available to print from your user history page. Users must:

  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the activity post-test and evaluation.
Physicians, nurse practitioners, and PAs who successfully complete the post-test and evaluation will receive CME/CE credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation. A copy of your certificate will be saved in your CME History on myCME.

If you have questions about this CME/CE activity, please contact AKH Inc. at tbrignoni@akhcme.com.
Add to Queue